Evaluate the role of Singhasyadi Kwatha in the management of Gout
Phase 2
- Conditions
- Health Condition 1: M255- Pain in joint
- Registration Number
- CTRI/2022/11/047494
- Lead Sponsor
- DSRRAU Jodhpur Rajasthan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of either sex in the age group between 20-70 years
2.Diagnosed and confirmed case of Vatarakta(Gout)
3.Patients having serum uric acid level more than 6 mg/dl with or without any associated features like joint inflammation
4.Willing to participate and able to provide signed informed consent
Exclusion Criteria
1.Patients below 20 years and above 70 years of age.
2.Patients suffering with other forms of Arthritis like Rheumatoid Arthritis, Ankylosing Spondylitis, Infective Arthritis, Osteoarthritis etc.
3.Pregnant and lactating mother.
4.Patients having any malignancy or any other severe systemic disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness SINGHASYADI KWATHA in the management OF Vatarakta of various etiological factorsTimepoint: 45 days for each patients and completion of trial within 6 months from the date of starting of trial
- Secondary Outcome Measures
Name Time Method To evaluate safety, sustainability and adverse drug reaction of trial drugTimepoint: 45 days